Abiraterone acetate, exemestane or the combination in postmenopausal patients with estrogen receptor-positive metastatic breast cancer

Abiraterone acetate, exemestane or the combination in postmenopausal patients with estrogen receptor-positive metastatic breast cancer

Item
http://www.wikidata.org/entity/Q34499512
Androgen Receptor: A Complex Therapeutic Target for Breast CancerThe CYP17A1 inhibitor abiraterone exhibits estrogen receptor agonist activity in breast cancer.The Metabolism, Analysis, and Targeting of Steroid Hormones in Breast and Prostate Cancer.Cotargeting of CYP-19 (aromatase) and emerging, pivotal signalling pathways in metastatic breast cancer.AR-Signaling in Human Malignancies: Prostate Cancer and Beyond.AR Signaling in Breast Cancer.Hormone receptor positive, HER2 negative metastatic breast cancer: A systematic review of the current treatment landscape.Hormone receptor positive, HER2 negative metastatic breast cancer: Future treatment landscape.A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1).Overcoming aromatase inhibitor resistance in breast cancer: possible mechanisms and clinical applications.Efficacy and safety in older patient subsets in studies of endocrine monotherapy versus combination therapy in patients with HR+/HER2- advanced breast cancer: a review.Enzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast Cancer.AR Expression in Breast Cancer CTCs Associates with Bone Metastases.Phase 1b study of orteronel in postmenopausal women with hormone-receptor positive (HR+) metastatic breast cancer.Clinical significance of androgen receptor expression in triple negative breast cancer-an immunohistochemistry study.The Divergent Function of Androgen Receptor in Breast Cancer; Analysis of Steroid Mediators and Tumor Intracrinology
P2860

Abiraterone acetate, exemestane or the combination in postmenopausal patients with estrogen receptor-positive metastatic breast cancer

Item
http://www.wikidata.org/entity/Q34499512
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Abiraterone acetate, exemestan ...... itive metastatic breast cancer
@ast
Abiraterone acetate, exemestan ...... itive metastatic breast cancer
@en
Abiraterone acetate, exemestan ...... itive metastatic breast cancer
@nl
type
label
Abiraterone acetate, exemestan ...... itive metastatic breast cancer
@ast
Abiraterone acetate, exemestan ...... itive metastatic breast cancer
@en
Abiraterone acetate, exemestan ...... itive metastatic breast cancer
@nl
prefLabel
Abiraterone acetate, exemestan ...... itive metastatic breast cancer
@ast
Abiraterone acetate, exemestan ...... itive metastatic breast cancer
@en
Abiraterone acetate, exemestan ...... itive metastatic breast cancer
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Abiraterone acetate, exemestan ...... itive metastatic breast cancer
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932